AI in genomics offers transformative opportunities by enhancing drug discovery and personalized medicine through efficient genomic data analysis. Drivers include the surge in genomic data, the focus ...

What if the thermal noise that hinders the efficiency of both classical and quantum computers could, instead, be used as a ...

Detailed price information for Alnylam Pharmaceuticals (ALNY-Q) from The Globe and Mail including charting and trades.

Overview AI medical diagnosis can recognize disease patterns even before symptoms worsenPredictive healthcare models delve into risk factors over the long termM ...

Glucose dysregulation may drive cerebral small vessel disease progression through microstructural brain damage, according to ...

Researchers from Duke Health and the University of Minnesota recently discovered that measuring specific tiny genetic ...

Alnylam is broadening its position in the area of RNA interference (RNAi) gene-silencing therapies for cardiovascular diseases via a partnership with Tenaya Therapeutics, claiming rights to use the ...

Researchers at the Lawrence Berkeley National Laboratory have developed a design and training framework ...

Tenaya leverages “human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) with high-throughput in vitro screening, imaging analysis, and machine learning algorithms” to identify new ...

Market Outlook and Growth TrajectoryThe global next generation sequencing market is poised to experience robust expansion, registering an estimated growth rate of around 15% over the next five years.

The global surge in electric vehicle adoption stands as a cornerstone of efforts to combat climate change and reduce reliance ...